
Computer Aided Detection System schemes are computer systems aiming at providing second opinions to physicians to aid in diagnoses. These systems compute outputs based on information from diverse sources, primarily from medical images captured using various methods. Computer Aided Detection System has become the most active field of research in medical imaging. Further, That CAD systems provide consistent interpretations of medical images to improve the precision of a diagnosis.
The global market for Computer-aided Detection and Diagnosis was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Computer-aided Detection and Diagnosis, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Computer-aided Detection and Diagnosis by region & country, by Type, and by Application.
The Computer-aided Detection and Diagnosis market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computer-aided Detection and Diagnosis.
Market Segmentation
By Company
IBM
Hologic
EDDA Technology
Siemens Healthcare
Philips Healthcare
GE Healthcare
Canon Medical Systems
ICAD( VuCOMP)
McKesson Corporation
Agfa-Gevaert N.V.
Riverain Technologies
Median Technologies
Segment by Type:
X-Ray Imaging
Computed Tomography
Ultrasound Imaging
Magnetic Resonance Imaging
Nuclear Medicine Imaging
Others
Segment by Application
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Liver Cancer
Boner Cancer
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Computer-aided Detection and Diagnosis manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Computer-aided Detection and Diagnosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Computer-aided Detection and Diagnosis in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Computer-aided Detection and Diagnosis Product Introduction
1.2 Global Computer-aided Detection and Diagnosis Market Size Forecast
1.3 Computer-aided Detection and Diagnosis Market Trends & Drivers
1.3.1 Computer-aided Detection and Diagnosis Industry Trends
1.3.2 Computer-aided Detection and Diagnosis Market Drivers & Opportunity
1.3.3 Computer-aided Detection and Diagnosis Market Challenges
1.3.4 Computer-aided Detection and Diagnosis Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Computer-aided Detection and Diagnosis Players Revenue Ranking (2023)
2.2 Global Computer-aided Detection and Diagnosis Revenue by Company (2019-2024)
2.3 Key Companies Computer-aided Detection and Diagnosis Manufacturing Base Distribution and Headquarters
2.4 Key Companies Computer-aided Detection and Diagnosis Product Offered
2.5 Key Companies Time to Begin Mass Production of Computer-aided Detection and Diagnosis
2.6 Computer-aided Detection and Diagnosis Market Competitive Analysis
2.6.1 Computer-aided Detection and Diagnosis Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Computer-aided Detection and Diagnosis Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computer-aided Detection and Diagnosis as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 X-Ray Imaging
3.1.2 Computed Tomography
3.1.3 Ultrasound Imaging
3.1.4 Magnetic Resonance Imaging
3.1.5 Nuclear Medicine Imaging
3.1.6 Others
3.2 Global Computer-aided Detection and Diagnosis Sales Value by Type
3.2.1 Global Computer-aided Detection and Diagnosis Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Computer-aided Detection and Diagnosis Sales Value, by Type (2019-2030)
3.2.3 Global Computer-aided Detection and Diagnosis Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Breast Cancer
4.1.2 Lung Cancer
4.1.3 Colorectal Cancer
4.1.4 Prostate Cancer
4.1.5 Liver Cancer
4.1.6 Boner Cancer
4.2 Global Computer-aided Detection and Diagnosis Sales Value by Application
4.2.1 Global Computer-aided Detection and Diagnosis Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Computer-aided Detection and Diagnosis Sales Value, by Application (2019-2030)
4.2.3 Global Computer-aided Detection and Diagnosis Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Computer-aided Detection and Diagnosis Sales Value by Region
5.1.1 Global Computer-aided Detection and Diagnosis Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Computer-aided Detection and Diagnosis Sales Value by Region (2019-2024)
5.1.3 Global Computer-aided Detection and Diagnosis Sales Value by Region (2025-2030)
5.1.4 Global Computer-aided Detection and Diagnosis Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Computer-aided Detection and Diagnosis Sales Value, 2019-2030
5.2.2 North America Computer-aided Detection and Diagnosis Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Computer-aided Detection and Diagnosis Sales Value, 2019-2030
5.3.2 Europe Computer-aided Detection and Diagnosis Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Computer-aided Detection and Diagnosis Sales Value, 2019-2030
5.4.2 Asia Pacific Computer-aided Detection and Diagnosis Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Computer-aided Detection and Diagnosis Sales Value, 2019-2030
5.5.2 South America Computer-aided Detection and Diagnosis Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Computer-aided Detection and Diagnosis Sales Value, 2019-2030
5.6.2 Middle East & Africa Computer-aided Detection and Diagnosis Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Computer-aided Detection and Diagnosis Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Computer-aided Detection and Diagnosis Sales Value
6.3 United States
6.3.1 United States Computer-aided Detection and Diagnosis Sales Value, 2019-2030
6.3.2 United States Computer-aided Detection and Diagnosis Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Computer-aided Detection and Diagnosis Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Computer-aided Detection and Diagnosis Sales Value, 2019-2030
6.4.2 Europe Computer-aided Detection and Diagnosis Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Computer-aided Detection and Diagnosis Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Computer-aided Detection and Diagnosis Sales Value, 2019-2030
6.5.2 China Computer-aided Detection and Diagnosis Sales Value by Type (%), 2023 VS 2030
6.5.3 China Computer-aided Detection and Diagnosis Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Computer-aided Detection and Diagnosis Sales Value, 2019-2030
6.6.2 Japan Computer-aided Detection and Diagnosis Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Computer-aided Detection and Diagnosis Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Computer-aided Detection and Diagnosis Sales Value, 2019-2030
6.7.2 South Korea Computer-aided Detection and Diagnosis Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Computer-aided Detection and Diagnosis Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Computer-aided Detection and Diagnosis Sales Value, 2019-2030
6.8.2 Southeast Asia Computer-aided Detection and Diagnosis Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Computer-aided Detection and Diagnosis Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Computer-aided Detection and Diagnosis Sales Value, 2019-2030
6.9.2 India Computer-aided Detection and Diagnosis Sales Value by Type (%), 2023 VS 2030
6.9.3 India Computer-aided Detection and Diagnosis Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 IBM
7.1.1 IBM Profile
7.1.2 IBM Main Business
7.1.3 IBM Computer-aided Detection and Diagnosis Products, Services and Solutions
7.1.4 IBM Computer-aided Detection and Diagnosis Revenue (US$ Million) & (2019-2024)
7.1.5 IBM Recent Developments
7.2 Hologic
7.2.1 Hologic Profile
7.2.2 Hologic Main Business
7.2.3 Hologic Computer-aided Detection and Diagnosis Products, Services and Solutions
7.2.4 Hologic Computer-aided Detection and Diagnosis Revenue (US$ Million) & (2019-2024)
7.2.5 Hologic Recent Developments
7.3 EDDA Technology
7.3.1 EDDA Technology Profile
7.3.2 EDDA Technology Main Business
7.3.3 EDDA Technology Computer-aided Detection and Diagnosis Products, Services and Solutions
7.3.4 EDDA Technology Computer-aided Detection and Diagnosis Revenue (US$ Million) & (2019-2024)
7.3.5 Siemens Healthcare Recent Developments
7.4 Siemens Healthcare
7.4.1 Siemens Healthcare Profile
7.4.2 Siemens Healthcare Main Business
7.4.3 Siemens Healthcare Computer-aided Detection and Diagnosis Products, Services and Solutions
7.4.4 Siemens Healthcare Computer-aided Detection and Diagnosis Revenue (US$ Million) & (2019-2024)
7.4.5 Siemens Healthcare Recent Developments
7.5 Philips Healthcare
7.5.1 Philips Healthcare Profile
7.5.2 Philips Healthcare Main Business
7.5.3 Philips Healthcare Computer-aided Detection and Diagnosis Products, Services and Solutions
7.5.4 Philips Healthcare Computer-aided Detection and Diagnosis Revenue (US$ Million) & (2019-2024)
7.5.5 Philips Healthcare Recent Developments
7.6 GE Healthcare
7.6.1 GE Healthcare Profile
7.6.2 GE Healthcare Main Business
7.6.3 GE Healthcare Computer-aided Detection and Diagnosis Products, Services and Solutions
7.6.4 GE Healthcare Computer-aided Detection and Diagnosis Revenue (US$ Million) & (2019-2024)
7.6.5 GE Healthcare Recent Developments
7.7 Canon Medical Systems
7.7.1 Canon Medical Systems Profile
7.7.2 Canon Medical Systems Main Business
7.7.3 Canon Medical Systems Computer-aided Detection and Diagnosis Products, Services and Solutions
7.7.4 Canon Medical Systems Computer-aided Detection and Diagnosis Revenue (US$ Million) & (2019-2024)
7.7.5 Canon Medical Systems Recent Developments
7.8 ICAD( VuCOMP)
7.8.1 ICAD( VuCOMP) Profile
7.8.2 ICAD( VuCOMP) Main Business
7.8.3 ICAD( VuCOMP) Computer-aided Detection and Diagnosis Products, Services and Solutions
7.8.4 ICAD( VuCOMP) Computer-aided Detection and Diagnosis Revenue (US$ Million) & (2019-2024)
7.8.5 ICAD( VuCOMP) Recent Developments
7.9 McKesson Corporation
7.9.1 McKesson Corporation Profile
7.9.2 McKesson Corporation Main Business
7.9.3 McKesson Corporation Computer-aided Detection and Diagnosis Products, Services and Solutions
7.9.4 McKesson Corporation Computer-aided Detection and Diagnosis Revenue (US$ Million) & (2019-2024)
7.9.5 McKesson Corporation Recent Developments
7.10 Agfa-Gevaert N.V.
7.10.1 Agfa-Gevaert N.V. Profile
7.10.2 Agfa-Gevaert N.V. Main Business
7.10.3 Agfa-Gevaert N.V. Computer-aided Detection and Diagnosis Products, Services and Solutions
7.10.4 Agfa-Gevaert N.V. Computer-aided Detection and Diagnosis Revenue (US$ Million) & (2019-2024)
7.10.5 Agfa-Gevaert N.V. Recent Developments
7.11 Riverain Technologies
7.11.1 Riverain Technologies Profile
7.11.2 Riverain Technologies Main Business
7.11.3 Riverain Technologies Computer-aided Detection and Diagnosis Products, Services and Solutions
7.11.4 Riverain Technologies Computer-aided Detection and Diagnosis Revenue (US$ Million) & (2019-2024)
7.11.5 Riverain Technologies Recent Developments
7.12 Median Technologies
7.12.1 Median Technologies Profile
7.12.2 Median Technologies Main Business
7.12.3 Median Technologies Computer-aided Detection and Diagnosis Products, Services and Solutions
7.12.4 Median Technologies Computer-aided Detection and Diagnosis Revenue (US$ Million) & (2019-2024)
7.12.5 Median Technologies Recent Developments
8 Industry Chain Analysis
8.1 Computer-aided Detection and Diagnosis Industrial Chain
8.2 Computer-aided Detection and Diagnosis Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Computer-aided Detection and Diagnosis Sales Model
8.5.2 Sales Channel
8.5.3 Computer-aided Detection and Diagnosis Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
IBM
Hologic
EDDA Technology
Siemens Healthcare
Philips Healthcare
GE Healthcare
Canon Medical Systems
ICAD( VuCOMP)
McKesson Corporation
Agfa-Gevaert N.V.
Riverain Technologies
Median Technologies
Ìý
Ìý
*If Applicable.
